We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Rockland Immunochemicals Acquires Epi-Plus Antibody Product Line

By LabMedica International staff writers
Posted on 15 Apr 2013
Rockland Immunochemicals, Inc. More...
(Gilbertsville, PA, USA), a biotechnology company focusing on antibodies and antibody based tools for basic research, assay development, and preclinical studies, acquired the Epi-Plus antibody product line from 21st Century Biochemicals, Inc.

These are regarded the most well validated antibodies available for epigenetics research. All Epi-Plus (Littleton, CO, USA) antibodies are multiassay validated, including dot blot testing using modified peptide arrays, western blots, and chromatin immunoprecipitation (ChIP).

The global revenue market for epigenetics has been estimated at USD 2.6 billion in 2012 and is expected to reach USD 8 billion by 2017, a five-year Compounded Annual Growth Rate (CAGR) of 25%. Rockland will market the Epi-Plus product line on its e-commerce website and through its existing global distribution network.

Dr. Jordan Fishman, president and CSO of 21st Century Biochemicals said, “As 21st Century Biochemicals continues to focus its efforts on providing US manufactured custom peptide and antibody solutions for its customers, we are pleased that the Epi-Plus product line is a strong strategic fit for the Rockland portfolio.”

Rockland Immunochemicals has supported the academic, biopharma, and diagnostic industries with antibodies and antibody based tools for over 50 years. At its US based facilities, Rockland produces and distributes reagents suited for integration into various assays performed on different platforms including western blot (WB), immunohistochemistry (IHC), immunofluorescence microscopy (IF), ELISA and FLOW cytometry. Additional information about Rockland’s products and services can be found on the company’s website.

Related Links:

Rockland Immunochemicals, Inc.
Epi-Plus



New
Gold Member
Blood Gas Analyzer
Stat Profile pHOx
3-Part Differential Hematology Analyzer
Swelab Alfa Plus Sampler
New
Clostridium Difficile Toxin A+B Combo Card Test
CerTest Clostridium Difficile Toxin A+B
New
Rapid Test Reader
DIA5000
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








DIASOURCE (A Biovendor Company)

Channels

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: The Volition Nu.Q nucleosome assay runs on the IDS i10 automated analyzer platform (Photo courtesy of VolitionRx)

Groundbreaking Lateral Flow Test Quantifies Nucleosomes in Whole Venous Blood in Minutes

Diagnosing immune disruptions quickly and accurately is crucial in conditions such as sepsis, where timely intervention is critical for patient survival. Traditional testing methods can be slow, expensive,... Read more

Pathology

view channel
Image: A real-time trial has shown that AI could speed cancer care (Photo courtesy of Campanella, et al., Nature Medicine)

AI Accurately Predicts Genetic Mutations from Routine Pathology Slides for Faster Cancer Care

Current cancer treatment decisions are often guided by genetic testing, which can be expensive, time-consuming, and not always available at leading hospitals. For patients with lung adenocarcinoma, a critical... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.